Abstract
Abstract
Background
Previous research using whole-brain neuroimaging techniques has revealed structural differences of grey matter (GM) in alcohol use disorder (AUD) patients. However, some of the findings diverge from other neuroimaging studies and require further replication. The quantity of relevant research has, thus far, been limited and the association between GM and abstinence duration of AUD patients has not yet been systematically reviewed.
Methods
The present research conducted a meta-analysis of voxel-based GM studies in AUD patients published before Jan 2021. The study utilised a whole brain-based d-mapping approach to explore GM changes in AUD patients, and further analysed the relationship between GM deficits, abstinence duration and individual differences.
Results
The current research included 23 studies with a sample size of 846 AUD patients and 878 controls. The d-mapping approach identified lower GM in brain regions including the right cingulate gyrus, right insula and left middle frontal gyrus in AUD patients compared to controls. Meta-regression analyses found increasing GM atrophy in the right insula associated with the longer mean abstinence duration of the samples in the studies in our analysis. GM atrophy was also found positively correlated with the mean age of the samples in the right insula, and positively correlated with male ratio in the left middle frontal gyrus.
Conclusions
GM atrophy was found in the cingulate gyrus and insula in AUD patients. These findings align with published meta-analyses, suggesting they are potential deficits for AUD patients. Abstinence duration, age and gender also affect GM atrophy in AUD patients. This research provides some evidence of the underlying neuroanatomical nature of AUD.
Funder
Department of Science and Technology of Sichuan Province
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health
Cited by
84 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Stress and substance use disorders: risk, relapse, and treatment outcomes;Journal of Clinical Investigation;2024-08-15
2. Unveiling Promising Neuroimaging Biomarkers for Schizophrenia Through Clinical and Genetic Perspectives;Neuroscience Bulletin;2024-05-04
3. Treatment of Psychiatric Emergencies;The American Psychiatric Association Publishing Textbook of Psychopharmacology;2024-03-22
4. Treatment of Autism Spectrum Disorder;The American Psychiatric Association Publishing Textbook of Psychopharmacology;2024-03-22
5. Treatment of Individuals With Intellectual Developmental Disorder;The American Psychiatric Association Publishing Textbook of Psychopharmacology;2024-03-22